Rigel Pharmaceuticals Inc (RIGL)
1.14
+0.01
(+0.88%)
USD |
NASDAQ |
Apr 23, 16:00
1.16
+0.02
(+1.75%)
After-Hours: 04:50
Rigel Pharmaceuticals 1 Year Total Returns (Daily): -4.20% for April 23, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 23, 2024 | -4.20% |
April 22, 2024 | -5.04% |
April 19, 2024 | -14.29% |
April 18, 2024 | -13.93% |
April 17, 2024 | -14.62% |
April 16, 2024 | -7.32% |
April 15, 2024 | -6.50% |
April 12, 2024 | 0.84% |
April 11, 2024 | 0.00% |
April 10, 2024 | -0.81% |
April 09, 2024 | 0.00% |
April 08, 2024 | 0.80% |
April 05, 2024 | 8.40% |
April 04, 2024 | 5.74% |
April 03, 2024 | 4.72% |
April 02, 2024 | 0.76% |
April 01, 2024 | 1.52% |
March 28, 2024 | 8.82% |
March 27, 2024 | 12.03% |
March 26, 2024 | 13.60% |
March 25, 2024 | 15.20% |
March 22, 2024 | 5.97% |
March 21, 2024 | 3.57% |
March 20, 2024 | 0.71% |
March 19, 2024 | -6.16% |
Date | Value |
---|---|
March 18, 2024 | -8.22% |
March 15, 2024 | -19.05% |
March 14, 2024 | -17.39% |
March 13, 2024 | -8.23% |
March 12, 2024 | -5.99% |
March 11, 2024 | -4.73% |
March 08, 2024 | -12.29% |
March 07, 2024 | 4.08% |
March 06, 2024 | 2.63% |
March 05, 2024 | -6.33% |
March 04, 2024 | -6.96% |
March 01, 2024 | -0.64% |
February 29, 2024 | 0.66% |
February 28, 2024 | 2.65% |
February 27, 2024 | -1.32% |
February 26, 2024 | -7.79% |
February 23, 2024 | -15.92% |
February 22, 2024 | -15.58% |
February 21, 2024 | -29.56% |
February 20, 2024 | -27.39% |
February 16, 2024 | -26.42% |
February 15, 2024 | -24.69% |
February 14, 2024 | -27.61% |
February 13, 2024 | -30.86% |
February 12, 2024 | -26.67% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-83.90%
Minimum
Jun 10 2022
213.0%
Maximum
Mar 18 2021
-2.22%
Average
-14.86%
Median
May 12 2020
1 Year Total Returns (Daily) Benchmarks
Nektar Therapeutics | 63.22% |
Avid Bioservices Inc | -66.35% |
Stereotaxis Inc | 43.82% |
Cara Therapeutics Inc | -82.79% |
Blueprint Medicines Corp | 88.24% |